Literature DB >> 21423873

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

David A Elliott1, Cyndi Shannon Weickert, Brett Garner.   

Abstract

The brain is the most lipid-rich organ in the body and, owing to the impermeable nature of the blood-brain barrier, lipid and lipoprotein metabolism within this organ is distinct from the rest of the body. Apolipoproteins play a well-established role in the transport and metabolism of lipids within the CNS; however, evidence is emerging that they also fulfill a number of functions that extend beyond lipid transport and are critical for healthy brain function. The importance of apolipoproteins in brain physiology is highlighted by genetic studies, where apolipoprotein gene polymorphisms have been identified as risk factors for several neurological diseases. Furthermore, the expression of brain apolipoproteins is significantly altered in several brain disorders. The purpose of this article is to provide an up-to-date assessment of the major apolipoproteins found in the brain (ApoE, ApoJ, ApoD and ApoA-I), covering their proposed roles and the factors influencing their level of expression. Particular emphasis is placed on associations with neurological and psychiatric disorders.

Entities:  

Year:  2010        PMID: 21423873      PMCID: PMC3058497          DOI: 10.2217/CLP.10.37

Source DB:  PubMed          Journal:  Clin Lipidol        ISSN: 1758-4302


  250 in total

1.  Altered apolipoprotein D expression in the brain of patients with Alzheimer disease.

Authors:  B Belloir; E Kövari; M Surini-Demiri; A Savioz
Journal:  J Neurosci Res       Date:  2001-04-01       Impact factor: 4.164

2.  A specific progesterone-binding component of human breast cyst fluid.

Authors:  W H Pearlman; J L Guériguian; M E Sawyer
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

3.  SP-40,40 immunoreactivity in inflammatory CNS lesions displaying astrocyte/oligodendrocyte interactions.

Authors:  E Wu; C F Brosnan; C S Raine
Journal:  J Neuropathol Exp Neurol       Date:  1993-03       Impact factor: 3.685

4.  Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition.

Authors:  R Tuteja; N Tuteja; C Melo; G Casari; F E Baralle
Journal:  FEBS Lett       Date:  1992-06-08       Impact factor: 4.124

5.  Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis.

Authors:  P Wong; J Pineault; J Lakins; D Taillefer; J Léger; C Wang; M Tenniswood
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

6.  Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein.

Authors:  R C Kowal; J Herz; K H Weisgraber; R W Mahley; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

7.  Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's disease.

Authors:  Svetlana Sarantseva; Svetlana Timoshenko; Olga Bolshakova; Eugenia Karaseva; Dmitry Rodin; Alexander L Schwarzman; Michael P Vitek
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

8.  Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides.

Authors:  Milla Koistinaho; Suizhen Lin; Xin Wu; Michail Esterman; Deanna Koger; Jeffrey Hanson; Richard Higgs; Feng Liu; Seema Malkani; Kelly R Bales; Steven M Paul
Journal:  Nat Med       Date:  2004-06-13       Impact factor: 53.440

9.  The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease.

Authors:  Radosveta P Koldamova; Iliya M Lefterov; Matthias Staufenbiel; Darren Wolfe; Shaohua Huang; Joseph C Glorioso; Michael Walter; Michael G Roth; John S Lazo
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  66 in total

1.  Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift.

Authors:  Mary Jo LaDu; Gregory W Munson; Lisa Jungbauer; Godfrey S Getz; Catherine A Reardon; Leon M Tai; Chunjiang Yu
Journal:  Biochim Biophys Acta       Date:  2011-11-23

2.  Role of Apolipoprotein E, Cathepsin D, and Brain-Derived Neurotrophic Factor in Parkinson's Disease: A Study from Eastern India.

Authors:  Prosenjit Pal; Tamal Sadhukhan; Subhadip Chakraborty; Sriparna Sadhukhan; Arindam Biswas; Shyamal K Das; Kunal Ray; Jharna Ray
Journal:  Neuromolecular Med       Date:  2019-05-28       Impact factor: 3.843

3.  A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults.

Authors:  Adam E Green; Jeremy R Gray; Colin G Deyoung; Timothy R Mhyre; Robert Padilla; Amanda M Dibattista; G William Rebeck
Journal:  Neuropsychologia       Date:  2014-01-02       Impact factor: 3.139

4.  Increased expression of ApoA1 after neuronal injury may be beneficial for healing.

Authors:  Mohor B Sengupta; Suparna Saha; Pradeep K Mohanty; Kiran K Mukhopadhyay; Debashis Mukhopadhyay
Journal:  Mol Cell Biochem       Date:  2016-10-13       Impact factor: 3.396

5.  Apolipoprotein A-I Crosses the Blood-Brain Barrier through Clathrin-Independent and Cholesterol-Mediated Endocytosis.

Authors:  Andrew L Zhou; Suresh K Swaminathan; Geoffry L Curran; Joseph F Poduslo; Val J Lowe; Ling Li; Karunya K Kandimalla
Journal:  J Pharmacol Exp Ther       Date:  2019-04-10       Impact factor: 4.030

Review 6.  Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.

Authors:  Robert W Mahley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-05-12       Impact factor: 8.311

7.  Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus.

Authors:  Elise V Mike; Hadijat M Makinde; Maria Gulinello; Kamala Vanarsa; Leal Herlitz; Gaurav Gadhvi; Deborah R Winter; Chandra Mohan; John G Hanly; C C Mok; Carla M Cuda; Chaim Putterman
Journal:  J Autoimmun       Date:  2018-08-30       Impact factor: 7.094

8.  A gene-brain-cognition pathway for the effect of an Alzheimer׳s risk gene on working memory in young adults.

Authors:  Benson W Stevens; Amanda M DiBattista; G William Rebeck; Adam E Green
Journal:  Neuropsychologia       Date:  2014-06-23       Impact factor: 3.139

9.  Phospholipid transfer protein is expressed in cerebrovascular endothelial cells and involved in high density lipoprotein biogenesis and remodeling at the blood-brain barrier.

Authors:  Anil Paul Chirackal Manavalan; Alexandra Kober; Jari Metso; Ingrid Lang; Tatjana Becker; Karin Hasslitzer; Martina Zandl; Elham Fanaee-Danesh; Jyotsna Brijesh Pippal; Vinay Sachdev; Dagmar Kratky; Jasminka Stefulj; Matti Jauhiainen; Ute Panzenboeck
Journal:  J Biol Chem       Date:  2013-12-25       Impact factor: 5.157

10.  Bipolar disorder with comorbid binge eating history: a genome-wide association study implicates APOB.

Authors:  Stacey J Winham; Alfredo B Cuellar-Barboza; Susan L McElroy; Alfredo Oliveros; Scott Crow; Colin L Colby; Doo-Sup Choi; Mohit Chauhan; Mark A Frye; Joanna M Biernacka
Journal:  J Affect Disord       Date:  2014-04-19       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.